000 | 01846 a2200469 4500 | ||
---|---|---|---|
005 | 20250513211808.0 | ||
264 | 0 | _c20000606 | |
008 | 200006s 0 0 eng d | ||
022 | _a0003-9926 | ||
024 | 7 |
_a10.1001/archinte.160.10.1455 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAgrawal, N M | |
245 | 0 | 0 |
_aSuperiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. _h[electronic resource] |
260 |
_bArchives of internal medicine _cMay 2000 |
||
300 |
_a1455-61 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a2-Pyridinylmethylsulfinylbenzimidazoles |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
650 | 0 | 4 |
_aAnti-Ulcer Agents _xadverse effects |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHelicobacter Infections _xdrug therapy |
650 | 0 | 4 |
_aHelicobacter pylori _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLansoprazole |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOmeprazole _xadverse effects |
650 | 0 | 4 | _aProton Pump Inhibitors |
650 | 0 | 4 |
_aRanitidine _xadverse effects |
650 | 0 | 4 |
_aStomach Ulcer _xchemically induced |
650 | 0 | 4 |
_aWound Healing _xdrug effects |
700 | 1 | _aCampbell, D R | |
700 | 1 | _aSafdi, M A | |
700 | 1 | _aLukasik, N L | |
700 | 1 | _aHuang, B | |
700 | 1 | _aHaber, M M | |
773 | 0 |
_tArchives of internal medicine _gvol. 160 _gno. 10 _gp. 1455-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/archinte.160.10.1455 _zAvailable from publisher's website |
999 |
_c10778049 _d10778049 |